GGrantIndex
← Leaderboards

Maha Farhat

Massachusetts General Hospital

$7,486,819
Attributed
$7,486,819
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,486,819 · 4

By mechanism

R01$5,897,343 · 2
K01$1,123,043 · 1
R21$466,433 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis

Research focus

TuberculosisGeneticGenome SequencingMutationPhenotypeDrug ResistanceGenesMycobacterium TuberculosisPathogenWhole GenomeGenomeAntibioticsProspectivePerformanceDiagnosisGeographyMonitorBioinformaticsTreatment OutcomePharmaceutical PreparationsResistanceInfectionCommunicable DiseasesInnovation

Grant awards (20)

An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis$427,444
R01 · FY2025 · AI · contact PI
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis$269,163
R01 · FY2025 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$750,803
R01 · FY2024 · AI · contact PI
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis$705,150
R01 · FY2024 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$22,729
R01 · FY2024 · AI · contact PI
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis$770,594
R01 · FY2023 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$680,731
R01 · FY2023 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$94,308
R01 · FY2023 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$71,579
R01 · FY2023 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$666,219
R01 · FY2022 · AI · contact PI
Human adaptation and transmissibility of Mycobacterium tuberculosis genetic lineages. A genomic epidemiology study to guide TB control$251,038
R21 · FY2022 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$656,764
R01 · FY2021 · AI · contact PI
Human adaptation and transmissibility of Mycobacterium tuberculosis genetic lineages. A genomic epidemiology study to guide TB control$215,395
R21 · FY2021 · AI · contact PI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics$781,859
R01 · FY2020 · AI · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$215,352
K01 · FY2019 · ES · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$220,530
K01 · FY2018 · ES · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$225,549
K01 · FY2017 · ES · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$181,451
K01 · FY2016 · ES · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$49,355
K01 · FY2016 · ES · contact PI
New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis$230,806
K01 · FY2015 · ES · contact PI